First in Indonesia: The Detection of COVID-19 by isothermal molecular test.

It is well documented that expedient and reliable testing is a critical tool in detecting and preventing the spread of the Covid-19 virus. Utilising a highly efficacious means of testing provides reassurance that members of the community can return to work, school, and other activities with a high degree of safety and confidence. BIMC hospital Bali, part of the Siloam Hospitals Group, is committed to providing patients a first-class service in compliance with international standards. In accordance with this commitment, BIMC Bali have invested in the first Abbott ID NOW rapid molecular isothermal test in Indonesia.

The isothermal molecular test is a new high-performance means of early detection of the COVID19 virus. A sample for this type of test is taken through a nasopharyngeal swab. The isothermal molecular test method  then utilizes isothermal nucleic acid amplification, resulting in a shorter examination process time, with results returned in 15 minutes time. The analysis is conducted at the point of care and displays the results as simply a positive or negative to eliminate any confusion. In general, a positive test result indicates that you are most likely infected with COVID-19. However, a negative result does not rule out the possibility of COVID-19. Further tests will need to be carried out within 48 hours to confirm the results.

The ID NOW isothermal molecular assay is backed by a certification from the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) and was CLIA certified for tests that can be used outside the laboratory,  referred to as POCT (Point of Care Test). The sensitivity of this method of testing is impressive at 95.0%, while the specificity is a robust 97.9%. This means that the results are of a  very high degree of accuracy.

You should consult your Doctor to discuss the results of testing immediately if you have tested positive. Your Doctor will guide you on the appropriate steps to take to keep you and your loved ones safe in the event of a COVID-19 exposure.

This molecular-based isothermal test for Covid-19 early screening is available at BIMC Hospital at IDR 1,299,000. For corporate deals, please contact Fransiska at +62 8111 077 003 (WhatsApp only).

Stay updated, subscribe to our newsletter!
Fill in your details below to get our newsletters in your inbox daily.
We respect your privacy.